AU4018201A - Molecules for diagnostics and therapeutics - Google Patents

Molecules for diagnostics and therapeutics

Info

Publication number
AU4018201A
AU4018201A AU40182/01A AU4018201A AU4018201A AU 4018201 A AU4018201 A AU 4018201A AU 40182/01 A AU40182/01 A AU 40182/01A AU 4018201 A AU4018201 A AU 4018201A AU 4018201 A AU4018201 A AU 4018201A
Authority
AU
Australia
Prior art keywords
therapeutics
diagnostics
molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU40182/01A
Inventor
Stefan Amshey
Steven C. Banville
Shawn R. Bratcher
Michael S. Chalup
Wensheng Chen
Howard J. Cohen
Gerard E. Dufour
Willy T. Fong
Lila B. Greenawalt
Jennifer L. Hillman
David M. Hodgson
Anissa Lee Jones
Stephen E. Lincoln
Tommy F. Lui
Scott R. Panzer
Ann M. Roseberry
Bruce H. Rosen
Frank D. Russo
Purvi Shah
Peter A. Spiro
Theresa K. Stockdreher
Rachel J. Wright
Pierre E. Yap
Jimmy Y. Yu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc
Publication of AU4018201A publication Critical patent/AU4018201A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
AU40182/01A 1999-09-23 2000-09-19 Molecules for diagnostics and therapeutics Abandoned AU4018201A (en)

Applications Claiming Priority (49)

Application Number Priority Date Filing Date Title
US15576099P 1999-09-23 1999-09-23
US60/155760 1999-09-23
US15593999P 1999-09-24 1999-09-24
US15629499P 1999-09-24 1999-09-24
US60/155939 1999-09-24
US60/156294 1999-09-24
US15662599P 1999-09-28 1999-09-28
US15656599P 1999-09-28 1999-09-28
US15662499P 1999-09-28 1999-09-28
US60/156624 1999-09-28
US60/156625 1999-09-28
US60/156565 1999-09-28
US16745399P 1999-11-23 1999-11-23
US16752299P 1999-11-24 1999-11-24
US16751799P 1999-11-24 1999-11-24
US16754299P 1999-11-24 1999-11-24
US16752199P 1999-11-24 1999-11-24
US16741099P 1999-11-24 1999-11-24
US16752099P 1999-11-24 1999-11-24
US60/167410 1999-11-24
US60/167521 1999-11-24
US60/167517 1999-11-24
US60/167522 1999-11-24
US60/167453 1999-11-24
US60/167520 1999-11-24
US60/167542 1999-11-24
US16794399P 1999-11-29 1999-11-29
US16794599P 1999-11-29 1999-11-29
US60/167945 1999-11-29
US60/167943 1999-11-29
US16843299P 1999-11-30 1999-11-30
US16826599P 1999-11-30 1999-11-30
US16819799P 1999-11-30 1999-11-30
US16842999P 1999-11-30 1999-11-30
US60/168432 1999-11-30
US60/168265 1999-11-30
US60/168429 1999-11-30
US60/168197 1999-11-30
US16846899P 1999-12-01 1999-12-01
US16859999P 1999-12-01 1999-12-01
US60/168468 1999-12-01
US60/168599 1999-12-01
US16885799P 1999-12-02 1999-12-02
US16861199P 1999-12-02 1999-12-02
US16861399P 1999-12-02 1999-12-02
US60/168611 1999-12-02
US60/168857 1999-12-02
US60/168613 1999-12-02
PCT/US2000/025643 WO2001021836A2 (en) 1999-09-23 2000-09-19 Molecules for diagnostics and therapeutics

Publications (1)

Publication Number Publication Date
AU4018201A true AU4018201A (en) 2001-04-24

Family

ID=27586739

Family Applications (1)

Application Number Title Priority Date Filing Date
AU40182/01A Abandoned AU4018201A (en) 1999-09-23 2000-09-19 Molecules for diagnostics and therapeutics

Country Status (3)

Country Link
AU (1) AU4018201A (en)
CA (1) CA2385496A1 (en)
WO (1) WO2001021836A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001072777A2 (en) * 2000-03-13 2001-10-04 Incyte Genomics, Inc. Human transcription factors
WO2018151821A1 (en) 2017-02-17 2018-08-23 Bristol-Myers Squibb Company Antibodies to alpha-synuclein and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2582897A (en) * 1996-03-15 1997-10-01 Millennium Pharmaceuticals, Inc. Compositions and methods for the diagnosis, prevention, and treatment of neoplastic cell growth and proliferation
EP0948531A1 (en) * 1996-12-11 1999-10-13 Chiron Corporation Secreted human proteins
CA2292788A1 (en) * 1997-06-11 1998-12-17 Abbott Laboratories Reagents and methods useful for detecting diseases of the lung
WO1999002724A2 (en) * 1997-07-11 1999-01-21 Mount Sinai Hospital Corporation Methods for identifying genes expressed in selected lineages, and a novel genes identified using the methods
WO1999046293A1 (en) * 1998-03-12 1999-09-16 Shanghai Second Medical University A zinc finger protein derived from hematopoietic cells
CA2296792A1 (en) * 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
EP1194549A2 (en) * 1999-07-02 2002-04-10 Chiron Corporation Human genes and gene expression products
JP2003505082A (en) * 1999-07-26 2003-02-12 ジェネンテック・インコーポレーテッド Novel polynucleotides and their uses

Also Published As

Publication number Publication date
WO2001021836A3 (en) 2002-01-31
WO2001021836A2 (en) 2001-03-29
CA2385496A1 (en) 2001-03-29

Similar Documents

Publication Publication Date Title
AU2002344208A1 (en) Molecules for diagnostics and therapeutics
AU2003289716A1 (en) Molecules for diagnostics and therapeutics
AUPQ023299A0 (en) Cucurbiturils and method for synthesis
AU2001288249A1 (en) Biosensors and methods for their use
AU3215500A (en) Compounds and methods
AUPQ297099A0 (en) Seating system
AUPQ339899A0 (en) Novel molecules
AU2678800A (en) Modified calycins
AU5724000A (en) Anastomosis system and methods for use
AU4625100A (en) Stable catalysts and processes for making and using the same
AU1083501A (en) Antibiotic-metal complex and methods
AUPP810399A0 (en) Catalytic molecules
AU2587399A (en) Human transport-associated molecules
AU2003210518A1 (en) Molecules for diagnostics and therapeutics
AU4198899A (en) Stabilized composition based on pyridinyl-sulfinyl-benzimidazoles and process
AU1734801A (en) Processes for producing tetrahydropyranyl-4-sulfonate and 4-aminotetrahydropyrancompound
AU4018201A (en) Molecules for diagnostics and therapeutics
AU2136401A (en) P450rai-2 and related proteins
AU6038700A (en) Sewer system and parts therefor
EP1031954A3 (en) Measuring arrangement and method
AU4940800A (en) Polyketides and their synthesis
AU5008000A (en) Molecules expressed in hippocampus
AU5320900A (en) Molecules for diagnostics and therapeutics
AU2007234466B2 (en) Seating system
AU3079900A (en) Internet-advertising method and system therefor

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase